25 XP   0   0   10

Sirio Pharma
Buy, Hold or Sell?

Let's analyse Sirio Pharma together

PenkeI guess you are interested in Sirio Pharma. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Sirio Pharma. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Sirio Pharma

I send you an email if I find something interesting about Sirio Pharma.

Quick analysis of Sirio Pharma (30 sec.)










What can you expect buying and holding a share of Sirio Pharma? (30 sec.)

How much money do you get?

How much money do you get?
¥0.23
When do you have the money?
1 year
How often do you get paid?
100.0%

What is your share worth?

Current worth
¥14.88
Expected worth in 1 year
¥18.33
How sure are you?
100.0%

+ What do you gain per year?

Total Gains per Share
¥5.13
Return On Investment
13.1%

For what price can you sell your share?

Current Price per Share
¥39.07
Expected price per share
¥36.98 - ¥39.41
How sure are you?
50%

1. Valuation of Sirio Pharma (5 min.)




Live pricePrice per Share (EOD)

¥39.07

Intrinsic Value Per Share

¥2.32 - ¥5.22

Total Value Per Share

¥17.20 - ¥20.10

2. Growth of Sirio Pharma (5 min.)




Is Sirio Pharma growing?

Current yearPrevious yearGrowGrow %
How rich?$373m$351.4m$21.6m5.8%

How much money is Sirio Pharma making?

Current yearPrevious yearGrowGrow %
Making money$29.3m$32m-$2.6m-9.2%
Net Profit Margin8.5%9.8%--

How much money comes from the company's main activities?

3. Financial Health of Sirio Pharma (5 min.)




4. Comparing to competitors in the Packaged Foods industry (5 min.)




  Industry Rankings (Packaged Foods)  


Richest
#187 / 489

Most Revenue
#192 / 489

Most Profit
#128 / 489

Most Efficient
#104 / 489

What can you expect buying and holding a share of Sirio Pharma? (5 min.)

Welcome investor! Sirio Pharma's management wants to use your money to grow the business. In return you get a share of Sirio Pharma.

What can you expect buying and holding a share of Sirio Pharma?

First you should know what it really means to hold a share of Sirio Pharma. And how you can make/lose money.

Speculation

The Price per Share of Sirio Pharma is ¥39.07. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Sirio Pharma.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Sirio Pharma, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is ¥14.88. Based on the TTM, the Book Value Change Per Share is ¥0.86 per quarter. Based on the YOY, the Book Value Change Per Share is ¥1.99 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is ¥0.42 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Sirio Pharma.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 ¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share
Usd Eps0.160.4%0.160.4%0.180.5%0.160.4%0.200.5%
Usd Book Value Change Per Share0.120.3%0.120.3%0.280.7%0.320.8%0.290.8%
Usd Dividend Per Share0.060.1%0.060.1%0.060.1%0.040.1%0.080.2%
Usd Total Gains Per Share0.180.5%0.180.5%0.330.8%0.360.9%0.371.0%
Usd Price Per Share5.08-5.08-5.76-6.41-4.58-
Price to Earnings Ratio31.45-31.45-32.66-41.52-29.66-
Price-to-Total Gains Ratio28.67-28.67-17.42-29.75-29.75-
Price to Book Ratio2.47-2.47-2.98-3.77-2.69-
Price-to-Total Gains Ratio28.67-28.67-17.42-29.75-29.75-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share5.395567
Number of shares185
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.060.04
Usd Book Value Change Per Share0.120.32
Usd Total Gains Per Share0.180.36
Gains per Quarter (185 shares)32.7666.26
Gains per Year (185 shares)131.05265.03
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
1438812126239255
28617625252478520
312826538379716785
41713535141059551050
521444164513111941315
625752977615714331580
730061890718416721845
8343706103821019102110
9385794116923621492375
10428882130026223882640

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%7.00.00.0100.0%7.00.00.0100.0%
Book Value Change Per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%7.00.00.0100.0%7.00.00.0100.0%
Dividend per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%7.00.00.0100.0%7.00.00.0100.0%
Total Gains per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%7.00.00.0100.0%7.00.00.0100.0%

Fundamentals of Sirio Pharma

About Sirio Pharma

Sirio Pharma Co., Ltd. operates as a contract manufacturer for dietary supplement industry worldwide. The company develops and manufactures a range of softgel dietary supplements; vegetarian softgel; nutraceutical gummies; probiotic products; tablet and powder products; capsules; and functional beverages. It also offers a range of services, including primary and final packaging. Sirio Pharma Co., Ltd. was founded in 1993 and is headquartered in Shantou, China.

Fundamental data was last updated by Penke on 2024-04-23 08:44:02.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a profit.
Using its assets, the company is efficient in making profit.
Using its investors money, the company is less efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating less efficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is just able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is overpriced.
Based on how much money comes from the company's main activities, the company is fair priced.

1.1. Profitability of Sirio Pharma.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Sirio Pharma earns for each ¥1 of revenue.

  • Above 10% is considered healthy but always compare Sirio Pharma to the Packaged Foods industry mean.
  • A Net Profit Margin of 8.5% means that ¥0.08 for each ¥1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Sirio Pharma:

  • The MRQ is 8.5%. The company is making a profit. +1
  • The TTM is 8.5%. The company is making a profit. +1
Trends
Current periodCompared to+/- 
MRQ8.5%TTM8.5%0.0%
TTM8.5%YOY9.8%-1.3%
TTM8.5%5Y10.5%-2.0%
5Y10.5%10Y21.4%-10.9%
Compared to industry (Packaged Foods)
PeriodCompanyIndustry (mean)+/- 
MRQ8.5%3.0%+5.5%
TTM8.5%2.9%+5.6%
YOY9.8%2.9%+6.9%
5Y10.5%3.2%+7.3%
10Y21.4%3.6%+17.8%
1.1.2. Return on Assets

Shows how efficient Sirio Pharma is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Sirio Pharma to the Packaged Foods industry mean.
  • 5.1% Return on Assets means that Sirio Pharma generated ¥0.05 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Sirio Pharma:

  • The MRQ is 5.1%. Using its assets, the company is efficient in making profit. +1
  • The TTM is 5.1%. Using its assets, the company is efficient in making profit. +1
Trends
Current periodCompared to+/- 
MRQ5.1%TTM5.1%0.0%
TTM5.1%YOY6.1%-1.0%
TTM5.1%5Y8.0%-2.9%
5Y8.0%10Y13.8%-5.7%
Compared to industry (Packaged Foods)
PeriodCompanyIndustry (mean)+/- 
MRQ5.1%1.3%+3.8%
TTM5.1%1.3%+3.8%
YOY6.1%1.3%+4.8%
5Y8.0%1.4%+6.6%
10Y13.8%1.6%+12.2%
1.1.3. Return on Equity

Shows how efficient Sirio Pharma is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Sirio Pharma to the Packaged Foods industry mean.
  • 7.9% Return on Equity means Sirio Pharma generated ¥0.08 for each ¥1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Sirio Pharma:

  • The MRQ is 7.9%. Using its investors money, the company is less efficient in making profit.
  • The TTM is 7.9%. Using its investors money, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ7.9%TTM7.9%0.0%
TTM7.9%YOY9.1%-1.3%
TTM7.9%5Y12.4%-4.5%
5Y12.4%10Y33.0%-20.6%
Compared to industry (Packaged Foods)
PeriodCompanyIndustry (mean)+/- 
MRQ7.9%2.9%+5.0%
TTM7.9%2.7%+5.2%
YOY9.1%3.0%+6.1%
5Y12.4%2.9%+9.5%
10Y33.0%3.1%+29.9%

1.2. Operating Efficiency of Sirio Pharma.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Sirio Pharma is operating .

  • Measures how much profit Sirio Pharma makes for each ¥1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Sirio Pharma to the Packaged Foods industry mean.
  • An Operating Margin of 9.7% means the company generated ¥0.10  for each ¥1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Sirio Pharma:

  • The MRQ is 9.7%. The company is operating less efficient.
  • The TTM is 9.7%. The company is operating less efficient.
Trends
Current periodCompared to+/- 
MRQ9.7%TTM9.7%0.0%
TTM9.7%YOY11.9%-2.2%
TTM9.7%5Y11.8%-2.1%
5Y11.8%10Y27.9%-16.1%
Compared to industry (Packaged Foods)
PeriodCompanyIndustry (mean)+/- 
MRQ9.7%5.1%+4.6%
TTM9.7%3.6%+6.1%
YOY11.9%4.9%+7.0%
5Y11.8%5.2%+6.6%
10Y27.9%5.1%+22.8%
1.2.2. Operating Ratio

Measures how efficient Sirio Pharma is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Packaged Foods industry mean).
  • An Operation Ratio of 1.58 means that the operating costs are ¥1.58 for each ¥1 in net sales.

Let's take a look of the Operating Ratio trends of Sirio Pharma:

  • The MRQ is 1.585. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.585. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.585TTM1.5850.000
TTM1.585YOY1.548+0.037
TTM1.5855Y1.544+0.040
5Y1.54410Y1.555-0.010
Compared to industry (Packaged Foods)
PeriodCompanyIndustry (mean)+/- 
MRQ1.5851.556+0.029
TTM1.5851.515+0.070
YOY1.5481.467+0.081
5Y1.5441.404+0.140
10Y1.5551.262+0.293

1.3. Liquidity of Sirio Pharma.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Sirio Pharma is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Packaged Foods industry mean).
  • A Current Ratio of 5.18 means the company has ¥5.18 in assets for each ¥1 in short-term debts.

Let's take a look of the Current Ratio trends of Sirio Pharma:

  • The MRQ is 5.179. The company is very able to pay all its short-term debts. +2
  • The TTM is 5.179. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ5.179TTM5.1790.000
TTM5.179YOY5.759-0.580
TTM5.1795Y3.964+1.215
5Y3.96410Y3.156+0.808
Compared to industry (Packaged Foods)
PeriodCompanyIndustry (mean)+/- 
MRQ5.1791.561+3.618
TTM5.1791.607+3.572
YOY5.7591.609+4.150
5Y3.9641.638+2.326
10Y3.1561.615+1.541
1.3.2. Quick Ratio

Measures if Sirio Pharma is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Sirio Pharma to the Packaged Foods industry mean.
  • A Quick Ratio of 1.15 means the company can pay off ¥1.15 for each ¥1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Sirio Pharma:

  • The MRQ is 1.147. The company is just able to pay all its short-term debts with the most liquid assets.
  • The TTM is 1.147. The company is just able to pay all its short-term debts with the most liquid assets.
Trends
Current periodCompared to+/- 
MRQ1.147TTM1.1470.000
TTM1.147YOY2.625-1.477
TTM1.1475Y1.366-0.218
5Y1.36610Y1.103+0.263
Compared to industry (Packaged Foods)
PeriodCompanyIndustry (mean)+/- 
MRQ1.1470.554+0.593
TTM1.1470.575+0.572
YOY2.6250.608+2.017
5Y1.3660.695+0.671
10Y1.1030.724+0.379

1.4. Solvency of Sirio Pharma.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Sirio Pharma assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Sirio Pharma to Packaged Foods industry mean.
  • A Debt to Asset Ratio of 0.35 means that Sirio Pharma assets are financed with 35.5% credit (debt) and the remaining percentage (100% - 35.5%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Sirio Pharma:

  • The MRQ is 0.355. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.355. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.355TTM0.3550.000
TTM0.355YOY0.334+0.021
TTM0.3555Y0.306+0.048
5Y0.30610Y0.395-0.088
Compared to industry (Packaged Foods)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3550.485-0.130
TTM0.3550.493-0.138
YOY0.3340.484-0.150
5Y0.3060.486-0.180
10Y0.3950.492-0.097
1.4.2. Debt to Equity Ratio

Measures if Sirio Pharma is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Sirio Pharma to the Packaged Foods industry mean.
  • A Debt to Equity ratio of 54.9% means that company has ¥0.55 debt for each ¥1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Sirio Pharma:

  • The MRQ is 0.549. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.549. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.549TTM0.5490.000
TTM0.549YOY0.501+0.048
TTM0.5495Y0.489+0.060
5Y0.48910Y0.830-0.341
Compared to industry (Packaged Foods)
PeriodCompanyIndustry (mean)+/- 
MRQ0.5490.956-0.407
TTM0.5490.984-0.435
YOY0.5010.942-0.441
5Y0.4890.997-0.508
10Y0.8301.077-0.247

2. Market Valuation of Sirio Pharma

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ¥1 in earnings Sirio Pharma generates.

  • Above 15 is considered overpriced but always compare Sirio Pharma to the Packaged Foods industry mean.
  • A PE ratio of 31.45 means the investor is paying ¥31.45 for every ¥1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Sirio Pharma:

  • The EOD is 33.415. Based on the earnings, the company is overpriced. -1
  • The MRQ is 31.448. Based on the earnings, the company is overpriced. -1
  • The TTM is 31.448. Based on the earnings, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD33.415MRQ31.448+1.967
MRQ31.448TTM31.4480.000
TTM31.448YOY32.658-1.209
TTM31.4485Y41.524-10.075
5Y41.52410Y29.660+11.864
Compared to industry (Packaged Foods)
PeriodCompanyIndustry (mean)+/- 
EOD33.41513.934+19.481
MRQ31.44812.839+18.609
TTM31.44814.097+17.351
YOY32.65812.959+19.699
5Y41.52416.330+25.194
10Y29.66019.036+10.624
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Sirio Pharma:

  • The EOD is 46.926. Based on how much money comes from the company's main activities, the company is fair priced.
  • The MRQ is 44.163. Based on how much money comes from the company's main activities, the company is fair priced.
  • The TTM is 44.163. Based on how much money comes from the company's main activities, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD46.926MRQ44.163+2.762
MRQ44.163TTM44.1630.000
TTM44.163YOY-41.303+85.467
TTM44.1635Y69.844-25.680
5Y69.84410Y49.888+19.955
Compared to industry (Packaged Foods)
PeriodCompanyIndustry (mean)+/- 
EOD46.9263.663+43.263
MRQ44.1633.665+40.498
TTM44.1631.934+42.229
YOY-41.3030.004-41.307
5Y69.8441.494+68.350
10Y49.8881.455+48.433
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Sirio Pharma is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Packaged Foods industry mean).
  • A PB ratio of 2.47 means the investor is paying ¥2.47 for each ¥1 in book value.

Let's take a look of the Price to Book Ratio trends of Sirio Pharma:

  • The EOD is 2.626. Based on the equity, the company is underpriced. +1
  • The MRQ is 2.471. Based on the equity, the company is underpriced. +1
  • The TTM is 2.471. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD2.626MRQ2.471+0.155
MRQ2.471TTM2.4710.000
TTM2.471YOY2.975-0.504
TTM2.4715Y3.772-1.300
5Y3.77210Y2.694+1.078
Compared to industry (Packaged Foods)
PeriodCompanyIndustry (mean)+/- 
EOD2.6261.455+1.171
MRQ2.4711.487+0.984
TTM2.4711.462+1.009
YOY2.9751.750+1.225
5Y3.7721.856+1.916
10Y2.6942.397+0.297
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Sirio Pharma compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.8630.8630%1.994-57%2.337-63%2.126-59%
Book Value Per Share--14.87914.8790%14.016+6%11.190+33%8.815+69%
Current Ratio--5.1795.1790%5.759-10%3.964+31%3.156+64%
Debt To Asset Ratio--0.3550.3550%0.334+6%0.306+16%0.395-10%
Debt To Equity Ratio--0.5490.5490%0.501+10%0.489+12%0.830-34%
Dividend Per Share--0.4190.4190%0.399+5%0.257+63%0.570-27%
Eps--1.1691.1690%1.277-8%1.154+1%1.460-20%
Free Cash Flow Per Share--0.8330.8330%-1.010+221%0.081+934%-0.164+120%
Free Cash Flow To Equity Per Share--0.4040.4040%3.981-90%1.654-76%0.690-42%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--5.219--------
Intrinsic Value_10Y_min--2.323--------
Intrinsic Value_1Y_max--0.206--------
Intrinsic Value_1Y_min--0.120--------
Intrinsic Value_3Y_max--0.860--------
Intrinsic Value_3Y_min--0.461--------
Intrinsic Value_5Y_max--1.806--------
Intrinsic Value_5Y_min--0.908--------
Market Cap7093627340.000+6%6676034740.0006676034740.0000%7571135400.000-12%8430294046.480-21%6021638604.629+11%
Net Profit Margin--0.0850.0850%0.098-13%0.105-19%0.214-60%
Operating Margin--0.0970.0970%0.119-18%0.118-18%0.279-65%
Operating Ratio--1.5851.5850%1.548+2%1.544+3%1.555+2%
Pb Ratio2.626+6%2.4712.4710%2.975-17%3.772-34%2.694-8%
Pe Ratio33.415+6%31.44831.4480%32.658-4%41.524-24%29.660+6%
Price Per Share39.070+6%36.77036.7700%41.700-12%46.432-21%33.166+11%
Price To Free Cash Flow Ratio46.926+6%44.16344.1630%-41.303+194%69.844-37%49.888-11%
Price To Total Gains Ratio30.467+6%28.67328.6730%17.420+65%29.747-4%29.747-4%
Quick Ratio--1.1471.1470%2.625-56%1.366-16%1.103+4%
Return On Assets--0.0510.0510%0.061-16%0.080-37%0.138-63%
Return On Equity--0.0790.0790%0.091-14%0.124-37%0.330-76%
Total Gains Per Share--1.2821.2820%2.394-46%2.593-51%2.696-52%
Usd Book Value--373080462.659373080462.6590%351434077.429+6%280565598.379+33%221024012.693+69%
Usd Book Value Change Per Share--0.1190.1190%0.275-57%0.323-63%0.294-59%
Usd Book Value Per Share--2.0552.0550%1.936+6%1.545+33%1.217+69%
Usd Dividend Per Share--0.0580.0580%0.055+5%0.035+63%0.079-27%
Usd Eps--0.1610.1610%0.176-8%0.159+1%0.202-20%
Usd Free Cash Flow--20876113.03620876113.0360%-25314628.528+221%2019810.681+934%-4108629.578+120%
Usd Free Cash Flow Per Share--0.1150.1150%-0.139+221%0.011+934%-0.023+120%
Usd Free Cash Flow To Equity Per Share--0.0560.0560%0.550-90%0.228-76%0.095-42%
Usd Market Cap979629935.654+6%921960397.594921960397.5940%1045573798.740-12%1164223607.819-21%831588291.299+11%
Usd Price Per Share5.396+6%5.0785.0780%5.759-12%6.412-21%4.580+11%
Usd Profit--29316638.33429316638.3340%32016342.931-8%28924677.191+1%36601684.883-20%
Usd Revenue--346252857.176346252857.1760%327151665.890+6%279458857.198+24%241372119.070+43%
Usd Total Gains Per Share--0.1770.1770%0.331-46%0.358-51%0.372-52%
 EOD+4 -4MRQTTM+0 -0YOY+13 -225Y+17 -1810Y+16 -19

3.2. Fundamental Score

Let's check the fundamental score of Sirio Pharma based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1533.415
Price to Book Ratio (EOD)Between0-12.626
Net Profit Margin (MRQ)Greater than00.085
Operating Margin (MRQ)Greater than00.097
Quick Ratio (MRQ)Greater than11.147
Current Ratio (MRQ)Greater than15.179
Debt to Asset Ratio (MRQ)Less than10.355
Debt to Equity Ratio (MRQ)Less than10.549
Return on Equity (MRQ)Greater than0.150.079
Return on Assets (MRQ)Greater than0.050.051
Total7/10 (70.0%)

3.3. Technical Score

Let's check the technical score of Sirio Pharma based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5068.655
Ma 20Greater thanMa 5036.255
Ma 50Greater thanMa 10033.758
Ma 100Greater thanMa 20033.513
OpenGreater thanClose37.310
Total4/5 (80.0%)



Latest Balance Sheet

Balance Sheet of 2022-12-31. Currency in CNY. All numbers in thousands.

Summary
Total Assets4,185,817
Total Liabilities1,484,293
Total Stockholder Equity2,701,524
 As reported
Total Liabilities 1,484,293
Total Stockholder Equity+ 2,701,524
Total Assets = 4,185,817

Assets

Total Assets4,185,817
Total Current Assets2,432,557
Long-term Assets1,753,260
Total Current Assets
Cash And Cash Equivalents 1,501,603
Short-term Investments 79,130
Net Receivables 459,805
Inventory 232,579
Other Current Assets 28,579
Total Current Assets  (as reported)2,432,557
Total Current Assets  (calculated)2,301,696
+/- 130,861
Long-term Assets
Property Plant Equipment 1,331,543
Goodwill 163,053
Intangible Assets 216,925
Long-term Assets Other 7,136
Long-term Assets  (as reported)1,753,260
Long-term Assets  (calculated)1,718,657
+/- 34,603

Liabilities & Shareholders' Equity

Total Current Liabilities469,693
Long-term Liabilities1,014,600
Total Stockholder Equity2,701,524
Total Current Liabilities
Short Long Term Debt 156
Accounts payable 259,253
Other Current Liabilities 50,702
Total Current Liabilities  (as reported)469,693
Total Current Liabilities  (calculated)310,111
+/- 159,582
Long-term Liabilities
Long term Debt 908,357
Capital Lease Obligations Min Short Term Debt21,137
Other Liabilities 85,096
Long-term Liabilities Other 10
Deferred Long Term Liability 59,446
Long-term Liabilities  (as reported)1,014,600
Long-term Liabilities  (calculated)1,074,046
+/- 59,446
Total Stockholder Equity
Common Stock180,497
Retained Earnings 1,278,269
Other Stockholders Equity 195,131
Total Stockholder Equity (as reported)2,701,524
Total Stockholder Equity (calculated)1,653,897
+/- 1,047,627
Other
Capital Stock180,497
Common Stock Shares Outstanding 180,497
Net Invested Capital 3,610,036
Net Tangible Assets 2,360,142
Net Working Capital 1,962,864
Property Plant and Equipment Gross 1,331,543



Balance Sheet

Currency in CNY. All numbers in thousands.

 Trend2022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-31
> Total Assets 
1,461,986
1,287,781
1,543,576
2,359,032
2,649,637
3,820,110
4,185,817
4,185,8173,820,1102,649,6372,359,0321,543,5761,287,7811,461,986
   > Total Current Assets 
820,403
508,933
569,137
1,316,723
1,323,832
1,914,522
2,432,557
2,432,5571,914,5221,323,8321,316,723569,137508,933820,403
       Cash And Cash Equivalents 
269,465
114,823
72,374
395,396
216,704
715,544
1,501,603
1,501,603715,544216,704395,39672,374114,823269,465
       Short-term Investments 
0
0
0
0
473,494
530,768
79,130
79,130530,768473,4940000
       Net Receivables 
372,794
172,382
219,464
222,222
261,421
341,759
459,805
459,805341,759261,421222,222219,464172,382372,794
       Inventory 
156,492
192,838
227,944
204,310
266,769
239,613
232,579
232,579239,613266,769204,310227,944192,838156,492
       Other Current Assets 
18,444
28,891
49,355
494,794
56,640
51,994
28,579
28,57951,99456,640494,79449,35528,89118,444
   > Long-term Assets 
647,280
778,848
974,439
1,042,308
1,325,805
1,905,588
1,753,260
1,753,2601,905,5881,325,8051,042,308974,439778,848647,280
       Property Plant Equipment 
292,127
389,760
580,022
629,254
768,051
1,172,576
1,331,543
1,331,5431,172,576768,051629,254580,022389,760292,127
       Goodwill 
165,887
171,387
172,376
171,677
176,279
158,590
163,053
163,053158,590176,279171,677172,376171,387165,887
       Intangible Assets 
171,313
175,738
171,202
179,470
175,631
208,124
216,925
216,925208,124175,631179,470171,202175,738171,313
       Long-term Assets Other 
10,288
10,845
9,123
9,206
170,204
6,572
7,136
7,1366,572170,2049,2069,12310,84510,288
> Total Liabilities 
997,005
707,577
759,530
414,009
466,949
1,275,330
1,484,293
1,484,2931,275,330466,949414,009759,530707,577997,005
   > Total Current Liabilities 
792,272
411,568
521,939
301,375
387,058
332,442
469,693
469,693332,442387,058301,375521,939411,568792,272
       Short-term Debt 
226,854
99,539
165,529
35,082
0
0
0
00035,082165,52999,539226,854
       Short Long Term Debt 
226,854
99,539
165,529
35,082
1,607
117
156
1561171,60735,082165,52999,539226,854
       Accounts payable 
92,651
118,734
145,408
142,581
199,524
195,706
259,253
259,253195,706199,524142,581145,408118,73492,651
       Other Current Liabilities 
407,129
96,038
54,709
40,596
81,615
51,831
50,702
50,70251,83181,61540,59654,70996,038407,129
   > Long-term Liabilities 
225,902
296,009
237,591
112,633
79,891
942,889
1,014,600
1,014,600942,88979,891112,633237,591296,009225,902
       Capital Lease Obligations 
0
0
0
0
981
16,682
21,137
21,13716,6829810000
       Long-term Liabilities Other 
146,482
222,690
157,944
32,239
10
10
10
10101032,239157,944222,690146,482
       Deferred Long Term Liability 
51,426
49,419
50,854
52,796
48,545
52,997
59,446
59,44652,99748,54552,79650,85449,41951,426
> Total Stockholder Equity
464,981
580,204
784,045
1,945,023
2,182,687
2,544,780
2,701,524
2,701,5242,544,7802,182,6871,945,023784,045580,204464,981
   Common Stock
60,000
60,000
60,000
80,000
120,000
180,170
180,497
180,497180,170120,00080,00060,00060,00060,000
   Retained Earnings 
270,798
399,389
602,614
744,771
978,137
1,137,971
1,278,269
1,278,2691,137,971978,137744,771602,614399,389270,798
   Accumulated Other Comprehensive Income 0000000
   Capital Surplus 0000000
   Treasury Stock0000000



Balance Sheet

Currency in CNY. All numbers in thousands.




Cash Flow

Currency in CNY. All numbers in thousands.




Income Statement

Currency in CNY. All numbers in thousands.


Latest Income Statement (annual, 2022-12-31)

Gross Profit (+$)
totalRevenue2,507,262
Cost of Revenue-1,725,557
Gross Profit781,705781,705
 
Operating Income (+$)
Gross Profit781,705
Operating Expense-2,247,967
Operating Income259,295-1,466,262
 
Operating Expense (+$)
Research Development80,716
Selling General Administrative273,649
Selling And Marketing Expenses0
Operating Expense2,247,967354,365
 
Net Interest Income (+$)
Interest Income11,578
Interest Expense-42,771
Other Finance Cost-1,467
Net Interest Income-32,660
 
Pretax Income (+$)
Operating Income259,295
Net Interest Income-32,660
Other Non-Operating Income Expenses0
Income Before Tax (EBT)251,518259,295
EBIT - interestExpense = 199,819
251,518
255,057
Interest Expense42,771
Earnings Before Interest and Taxes (EBIT)242,590294,289
Earnings Before Interest and Taxes (EBITDA)426,031
 
After tax Income (+$)
Income Before Tax251,518
Tax Provision-39,233
Net Income From Continuing Ops212,286212,286
Net Income212,286
Net Income Applicable To Common Shares212,286
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses14,854
Total Other Income/Expenses Net032,660
 

Technical Analysis of Sirio Pharma
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Sirio Pharma. The general trend of Sirio Pharma is BULLISH with 100.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Sirio Pharma's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (100.0%) Bearish trend (-100.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Sirio Pharma.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 39.33 < 39.41.

The bearish price targets are: 38.56 > 37.97 > 36.98.

Tweet this
Sirio Pharma Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Sirio Pharma. The current mas is .

The long score for the Moving Averages is 14/14.
The longshort score for the Moving Averages is 14/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Sirio Pharma Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Sirio Pharma. The current macd is 0.80415057.

The long score for the Moving Average Convergence/Divergence (MACD) is 4/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 4/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Sirio Pharma price going up in the near term. +2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Sirio Pharma. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Sirio Pharma price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Sirio Pharma Daily Moving Average Convergence/Divergence (MACD) ChartSirio Pharma Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Sirio Pharma. The current adx is 32.76.

The long score for the Directional Movement Index (DMI) is 4/7.
The longshort score for the Directional Movement Index (DMI) is 4/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Sirio Pharma shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX > 25 && ADX trending up: The ADX is above 25 and indicates a strong bullish trend. The ADX is trending up, so the bullish trend is strengthening.
Sirio Pharma Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Sirio Pharma. The current sar is 34.31.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Sirio Pharma Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Sirio Pharma. The current rsi is 68.65. The current phase is Continuation in bull market.

The long score for the Relative Strength Index (RSI) is 4/13.
The longshort score for the Relative Strength Index (RSI) is 4/(-13 +13).

  • Continuation in bull market: Uptrend continues after a consolidation or pullback. Hold or add to existing positions.
  • Trending up: The RSI is trending up. +1
Sirio Pharma Daily Relative Strength Index (RSI) ChartSirio Pharma Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Sirio Pharma. The current phase is Overbought in bull market.

The long score for the Stochastic Oscillator is 6/6.
The longshort score for the Stochastic Oscillator is 6/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH > 80: The STOCH %K is above 80 and overbought. +2
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Sirio Pharma price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Sirio Pharma Daily Stochastic Oscillator ChartSirio Pharma Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Sirio Pharma. The current cci is 267.08.

The long score for the Commodity Channel Index (CCI) is 1/1.
The longshort score for the Commodity Channel Index (CCI) is 1/(-1 +1).

  • CCI > 100: The CCI is above 100, it indicates that the price is significantly above its average, suggesting a potential overbought condition. +1
Sirio Pharma Daily Commodity Channel Index (CCI) ChartSirio Pharma Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Sirio Pharma. The current cmo is 46.05.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Sirio Pharma Daily Chande Momentum Oscillator (CMO) ChartSirio Pharma Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Sirio Pharma. The current willr is -11.29326047.

The long score for the Williams %R is 1/1.
The longshort score for the Williams %R is 1/(-1 +1).

  • WILLR > -20: The Williams %R is above -20. This indicates that the price is in overbought territory, suggesting a potential price correction or trend reversal to the downside. +1
Sirio Pharma Daily Williams %R ChartSirio Pharma Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Sirio Pharma.

Sirio Pharma Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Sirio Pharma. The current atr is 1.82673943.

Sirio Pharma Daily Average True Range (ATR) ChartSirio Pharma Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Sirio Pharma. The current obv is 17,736,196.

Sirio Pharma Daily On-Balance Volume (OBV) ChartSirio Pharma Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Sirio Pharma. The current mfi is 71.51.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Sirio Pharma Daily Money Flow Index (MFI) ChartSirio Pharma Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Sirio Pharma.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-24CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-11-27SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-11-28MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-29RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2023-11-30MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2023-12-06SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2023-12-07CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-08STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-12STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-15STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-18MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2023-12-19STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-20CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-21STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2023-12-25CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-26STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-27SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-29WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-02STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-03CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-05SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-01-08DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-01-09DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-10CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-11CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-12MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-01-15STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-16STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-17STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-01-18CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-19MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-01-22DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-23STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-26STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-29BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-01-31RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-05STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-06RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-08SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-19MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-20DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-21STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-23SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-26CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-27STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-28SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-01STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-06STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-07STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-08STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-11DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-13MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-03-15STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-03-18MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-03-19STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-03-25STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-27CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-03-28STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-03CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-04-08MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-10STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-11STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-12STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-15STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-16CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-17SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-04-18SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-22SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-04-23MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.

6.3. Candlestick Patterns

Sirio Pharma Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Sirio Pharma based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5068.655
Ma 20Greater thanMa 5036.255
Ma 50Greater thanMa 10033.758
Ma 100Greater thanMa 20033.513
OpenGreater thanClose37.310
Total4/5 (80.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Sirio Pharma with someone you think should read this too:
  • Are you bullish or bearish on Sirio Pharma? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Sirio Pharma? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Sirio Pharma

I send you an email if I find something interesting about Sirio Pharma.


Comments

How you think about this?

Leave a comment

Stay informed about Sirio Pharma.

Receive notifications about Sirio Pharma in your mailbox!